
(HealthDay News) – Sanofi Inc. on Thursday became the third company to announce it will slash prices on its insulin products. The French company announced that it will cut prices by 78% and cap out-of-pocket charges for its insulin, brand named Lantus, at $35 per month. The company will also lower prices on its short-acting… read on > read on >